CSOP Hang Seng Biotech ETF (HKG:3174)
Hong Kong · Delayed Price · Currency is HKD 3.692
+0.214 (6.15%)
Last updated: Apr 1, 2026, 11:57 AM HKT
53.32% (1Y)
| Assets | 823.33M |
| Expense Ratio | 1.50% |
| PE Ratio | 26.68 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +51.08% |
| Volume | 2,943,100 |
| Open | 3.550 |
| Previous Close | 3.478 |
| Day's Range | 3.550 - 3.694 |
| 52-Week Low | 1.942 |
| 52-Week High | 4.456 |
| Beta | 0.70 |
| Holdings | 31 |
| Inception Date | Jul 21, 2021 |
About 3174
CSOP Hang Seng Biotech ETF is an exchange-traded fund directly investing in companies. It prefers to invest in companies based out of Hong Kong. It primarily invests the healthcare- pharmaceutical and medical device companies.
Asset Class Equity
Category Health Care
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3174
Provider CSOP
Index Tracked Hang Seng Biotech Index - HKD - Benchmark TR Net
Performance
3174 had a total return of 51.08% in the past year, including dividends. Since the fund's inception, the average annual return has been -15.92%.
Top 10 Holdings
69.42% of assets| Name | Symbol | Weight |
|---|---|---|
| Innovent Biologics, Inc. | 1801 | 10.36% |
| BeOne Medicines AG | 6160 | 9.47% |
| Akeso, Inc. | 9926 | 9.16% |
| WuXi Biologics (Cayman) Inc. | 2269 | 8.49% |
| CSPC Pharmaceutical Group Limited | 1093 | 7.37% |
| Sino Biopharmaceutical Limited | 1177 | 5.98% |
| WuXi AppTec Co., Ltd. | 2359 | 5.51% |
| Hansoh Pharmaceutical Group Company Limited | 3692 | 4.85% |
| 3SBio Inc. | 1530 | 4.79% |
| XtalPi Holdings Limited | 2228 | 3.45% |